-
France-Iraq World Cup game suspended due to severe weather alert
-
Romanian parliament rejects liberal PM-designate
-
US temporarily suspends Iran oil sanctions, says nuclear inspectors to return
-
Maduro ouster put Venezuela on 'the right path': interim leader
-
Missed penalty spurred 'very angry' Messi to World Cup history
-
Shooting in Montreal, Canada leaves three dead including suspect
-
Oil falls as US waives Iranian sanctions and Nasdaq tumbles
-
Balogun chases 'inevitable' Messi in wild Golden Boot race
-
Defeated Colombian leftist calls for calm after post-vote violence
-
Belgium's Doku becomes father after World Cup controversy
-
Messi sets World Cup scoring record as Argentina down Austria
-
Magic Messi makes World Cup history to send Argentina into last 32
-
French TV presenter stood down over Doku World Cup comments
-
Ghana coach Queiroz says playing England 'easiest' World Cup game
-
Messi sets World Cup scoring record with 17th goal
-
Former Bayern stalwart Demichelis takes over at RB Leipzig
-
Colombian leftist candidate calls for calm after post-vote violence
-
Andy Burnham: 'King of the North' with Downing Street in his sights
-
Britons cautiously optimistic after PM's resignation
-
Latest developments in Europe's heatwave
-
Draper makes winning return at Eastbourne with Murray on his side
-
IMF director says Iran war fallout creating 'difficult moment' for Africa
-
Argentina fans defiant, 40 years on from Maradona's 'Hand of God'
-
Hormuz: Traffic flows despite Iran's closure announcement
-
Wikipedia won't let AI edit articles, cofounder says
-
Clive Davis: the starmaker who shaped modern music
-
Uncapped Coles named in England's T20 squad to face India
-
Qatar gas plant blast kills 13, injures dozens
-
Andy Burnham: 'King of the North' eyes Downing Street throne
-
Oil falls as US waives Iranian crude sanctions
-
Dangerous 'heat stress' has surged worldwide, study shows
-
England captain Itoje rested for Nations Championship
-
Interstellar comet likely far older than Solar System: astronomers
-
Antoine Semenyo, Ghana's man on the inside and England threat
-
Man Utd secure land for proposed new 100,000-capacity stadium
-
Two children found dead in car as France faces hottest day of heatwave
-
US suspends Iran oil sanctions, says nuclear inspectors to return
-
Two children die in France as heatwave blasts Europe
-
Stokes and Atkinson cleared by Cricket Regulator after nightclub incident
-
Ex-Wimbledon champion Vondrousova banned four years for refusing drugs test
-
Veteran Le Roy named new coach of Congo
-
Milan-Cortina chief Malago elected new head of Italian FA
-
Germany's Schlotterbeck out of World Cup with ankle injury
-
Any unfreezing of Iranian funds will not finance terrorism: Vance
-
Vance hails 'good foundation' for Iran deal after direct talks
-
Alan Greenspan: longtime Fed chief with a divided legacy
-
Leinster boss Cullen to step down at end of next season
-
'Has-been' Belgium stars scorched after Iran World Cup draw
-
Oil falls on US-Iran progress; pound holds up as Starmer resigns
-
Starmer resigns as UK PM, Burnham favourite to take over
Biorasi Unveils New Website to Drive Sponsor Success with Biotech-Centric Strategies and Modular CRO Solutions
Relaunch puts customized CRO services front and center for today's Biotech and Biopharma innovators.
AVENTURA, FL / ACCESS Newswire / October 8, 2025 / Biorasi, a leading global full-service contract research organization (CRO), has relaunched its website to reflect a bold new direction: Empowering biotech sponsors with modular clinical trial solutions, AI-powered tools, and a renewed focus on sponsor-centric strategy.
"The future of clinical research belongs to those who can adapt, innovate, and deliver," said Chris O'Brien, CEO of Biorasi. "Our new website reflects a strategic evolution - one that puts biotech sponsors at the center of smarter, faster, and more flexible trials. It's a touchstone for the modular solutions and AI-powered tools that will define the next era of clinical success."
Key updates to the website include:
Focused Study Solutions: Critical standalone service offerings deliver the same high-performance features found in Biorasi's full-service strategies:
Study Rescue and Recovery Packages: Designed to salvage struggling clinical trials and restore timelines.
Flexible Data Sciences Solutions: Advanced analytics and biostatistics available as standalone services.
Specialized Services: Including Quality Assurance, Clinical Monitoring, and Safety & Pharmacovigilance, tailored to sponsor needs.
Accelerated Startup Modules: Fast-track solutions for trials requiring rapid market entry.
AI-Powered Feasibility: Dynamic clinical site modeling combined with targeted feasibility outreach and enrollment forecasting.
New Sponsor Strategy: A sharpened focus on the CRO competencies that matter most: Reliability, Flexibility, and Accessibility.
The redesigned website celebrates Biorasi's over two decades of industry leadership, clinical trial experience, and operational excellence:
Over 200 global studies executed.
Five FDA approvals in the past seven years.
$150M+ in recovered rescue studies.
6 weeks or less for database go-live.
Kickoff Meetings in 10 business days after LOI/WO.
60% repeat business from returning sponsors.
Studies conducted in 48 countries, reaching 65% of the global population.
About Biorasi
Biorasi is a global clinical research organization (CRO) that delivers speed-to-market strategies for small to midsized biotech and biopharma sponsors. With over two decades of expertise in running clinical trials across dermatology, oncology, neurology, nephrology, and other key therapeutic areas, Biorasi leverages reliable, flexible, and accessible solutions necessary to succeed in today's dynamic and evolving clinical trials industry. Contact Biorasi at [email protected] / (786) 388-0700.
SOURCE: Biorasi, LLC
View the original press release on ACCESS Newswire
A.O.Scott--AT